Mission
Creating a more personalized future of prostate cancer care.
Using deep learning, Avenda Health software maps a patient’s cancer in 3D, giving physicians never before available 3D visualization and precise information enabling more confident care plan decisions.
Dedicated to bringing this cutting-edge technology to all practices and physicians treating prostate cancer patients, Avenda Health aims to:
- Improve outcomes
- Preserve quality of life
- Create a new standard of cancer care
Guiding values
Transforming the standard of care
The team at Avenda Health is driven by developing cutting-edge AI software that will forever revolutionize prostate cancer care and offer every patient a precise treatment plan unique to them
Never losing sight of what matters
The team at Avenda Health is relentless in its mission to deliver high-quality care to all patients suffering from prostate cancer while reducing the growing burden of healthcare costs
Tirelessly pursuing excellence
The team at Avenda Health is comprised of world-class innovators and clinicians devoted to partnering with physicians everywhere to provide the best care and outcomes for their prostate cancer patients
Our Leadership
Our world-class team of innovators is comprised of experts in Urology, Artificial Intelligence (AI), and Medical Devices.
Shyam Natarajan, PhD
Founder / CEO
- Expertise in image-guided interventions, machine learning, and embedded systems
- Instrumental in the commercialization of targeted prostate biopsy creating and executing the foundational validation studies
- Led an NIH-funded lab as a professor at UCLA Urology, Surgery, and Bioengineering
Brit Berry-Pusey, PhD
Founder / COO
- 10+ years in Market Access, Contracts, Strategy, and Business Development in medical device, digital therapeutics, and pharma
- UCLA and Stanford Graduate School of Business training
- Expertise in Cardiology, Diabetes, Medical Imaging, Oncology, and Urology
Leonard S. Marks, MD
Founder / CMO
- Professor and deKernion Endowed Chair of Urology at UCLA
- Pioneer and world leader in Targeted Prostate Biopsy, Active Surveillance, and Focal Therapy
- 150+ peer-reviewed publications, 30+ clinical trials, 10+ federal grants
Carolyn Reul
VP Sales & Marketing
- 25+ years’ experience in the medical imaging industry
- Sales management, marketing, product and business development.
- Extensive experience in ultrasound imaging and guided intervention in urology – specialization in prostate and kidney, hepatobiliary, neurosurgery, interventional radiology and OB/GYN
Jemima Escamilla, PhD
VP of Business Development and Growth
- 9+ Years business development and venture investing experience for the medical device industry
- Extensive experience in competitive analysis, technical and financial diligence
- Early-stage company development expertise in various specialties including General Surgery, Neurovascular Surgery, and Opthamology
Cynthia Weaver
Senior Director of Clinical Affairs
- 25+ years in the Clinical Research industry with a focus on oversight, management and execution of medical device trials
- Expertise in clinical operations including development, leadership, and mentoring teams of clinical research professionals
- Passionate about the development of novel device treatments to enhance patient health especially in Class III devices
Kim Becker
Director Clinical Marketing and Education
- MS in Health Administration, RDMS, RVT
- 30 years in both healthcare setting and medical device industry specializing in diagnostic ultrasound in the urology, surgery, and radiology
- Expertise in clinical applications including product evaluation and training, education, and leadership of a national clinical team
Joshua Shubert
Director of Engineering
- M.S. in Electrical Engineering from Johns Hopkins
- Industry experience in cloud-based medical software
- Background in deep learning, medical imaging, and robotics
Phillip Allen
Director of Manufacturing Operations
- 12+ years of leadership experience
- Medical device industry background in Operations, Manufacturing Engineering, and New Product Introduction
- Business training from the London School of Economics and Kelley School of Business
Crystal Womack
Quality Manager
- BS in Chemical and Biomolecular Engineering from Georgia Tech
- Design and manufacturing quality expertise
- ISO 13485, ISO 14971 and Design Controls training
Jeremy Bong
Staff Cloud Engineer
- B.S. in Computer Science at University of Waterloo
- Background in cloud architecture and full-stack
- 10+ years experience in professional software development
Alan Priester, PhD
Senior Data Scientist
- 8+ years experience developing hardware and software for (and with) urologists
- PhD in biomedical engineering from UCLA, specializing in image-guided diagnosis and therapy
- Expertise in data science, medical imaging, and rapid prototyping
Mike Klein
Chairman and CEO
iCAD Medical
Shyam Natarajan, PhD
CEO
Avenda Health
Leonard Marks, MD
CMO
Avenda Health
Ron Sugar, PhD
Chairman, Uber
Board Director, Apple
Board Director, Amgen
Simon Stertzer, MD, FACC, FAHA, FACP
Serial Entrepreneur and Professor Emeritus
Stanford University
Peter T. Scardino, MD
Chair Emeritus, Dept of Surgery
Memorial Sloan-Kettering Cancer Center
Eric Klein, MD
Chairman, Glickman Urological and Kidney Institute
Cleveland Clinic
Alan Partin, MD
Chairman, Dept of Urology
Johns Hopkins
Stuart Holden, MD
Medical Director
Prostate Cancer Foundation
Michael Shabot, MD
Former Executive Vice President Memorial Hermann Partner
Relia Healthcare Advisors
Alec Koo, MD
Director
LUGPA
Merel Nissenberg, JD
President
National Alliance of State Prostate Cancer Coalitions
Scott Eggener, MD
Vice Chair, Urology
UChicago
Please note that Avenda Health does not employ third parties to conduct interviews on our behalf.